Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18f-fluorodeoxyglucose gated pet cardiac imaging comparative results

Nuclear Medicine Communications

Volumn 19, Issue 9, 1998, Pages 867-874

  SchrODer O ^a   Hor, G ^a   Hertel, A ^a   Baum, R P ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; NICOTINIC ACID DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG UPTAKE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; IMAGE QUALITY; MALE; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY;

EID: 0031787313     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199809000-00007     Document Type: Article

References (32)

1. Tillisch J, Brunken R, Marshall R et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
2. Eitzman D, Al Aouar Z, Kanter HL et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
3. Tamaki N, Yoshiharu Y, Yamashita K et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am f Cardiol 1989; 64: 860-865.
4. Schelbert H, Bonow RO, Geltman E, Maddahi J, Schwaiger M. Position statement: Clinical use of cardiac positron emission tomography-positioning paper of the Cardiovascular Council of the Society of Nuclear Medicine. J Nucl Med 1993; 34: 1385-1388.
5. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of excreted glucose in normal human myocardium. J Clin Invest 1985; 76: 1819-1827.
6. Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans: Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest 1988; 82: 2017-2025.
7. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: Basic principles and application to imaging by positron emission tomography. Prog Cardio-vasc Dis 1989; 32: 217-238.
8. Wisneski JA, Stanley WC, Neese RA, Gertz EW. Effect of acute hyperglycemia on myocardial glycolytic activity in humans. J Clin Invest 1990; 85: 1648-1656.
9. Nuutila P, Koivisto VA, Knuuti J et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992; 89: 1767-1774.
10. Lassers BW, Wahlqvist ML, Kaijser L, Carlson LA. Effect of nicotinic acid on myocardial metabolism in man at rest and during exercise. J Appl Physiol 1972; 33: 72-80.
11. Opie LH. Fuels: Carbohydrates and lipids. In: Opie LH, ed. The heart, physiology and metabolism. New York: Raven Press, 1991: 208-246.
12. Betty J, Baker J, Pieper K et al. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglu-cose and nitrogen-13-ammonia in normal volunteers. J Nucl Med 1991; 32: 1518-1525.
13. Gropler RJ, Siegel BA, Lee KJ et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J. Nucl Med 1990; 31: 1749-1756.
14. Knuuti MJ, Nuutila P, Ruotsalainen U et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33: 1255-1262.
15. Bonow RO, Berman DS, Gibbons RJ et al. Cardiac positron emission tomography: A report for health professionals from the Committee on Advanced Cardiac Imaging and Technology Council on Clinical Cardiology, American Heart Association. Circulation 1991; 84: 447-454.
16. Knuuti MJ, Yki-Jarvinen H, Voipo-Pulkki L-M et al. Enhancement of myocardial [fluorine-18]fluorodeoxyglu-cose uptake by a nicotinic acid derivative. J Nucl Med 1994; 35: 989-998.
17. Stone CK, Holden JE, Stanley W, Perlman SB. Effect of nicotinic acid on exogenous myocardial glucose utilization. J Nucl Med 1995; 36: 996-1002.
18. Bax JJ, Veening MA, Visser FC et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging: A comparative study using different protocols. Eur J Nucl Med 1997; 24: 35-41.
19. Melin JA, Becker LC. Quantitative relationship between global left ventricular thallium uptake and blood flow: Effects of propranolol, ouabain, dipyridamole and coronary artery occlusion. J Nucl Med 1986; 27: 641-652.
20. Kadish AH, Little RL, Sternberg JC. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968; 14: 116-131.
21. Miles J, Glassock R, Aikens J, Gerich J, Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 1983; 24: 96-99.
22. Kuzuya H, Blix BM, Horwitz DL, Steiner DF, Rubenstein A. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977; 26: 22-29.
23. Vom Dahl J, Hermann WH, Hicks RJ et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed by positron emission tomography. Circulation 1993; 88: 395-404.
24. Ohtake T, Yokoyama I, Watanabe T et al. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 1995; 36: 456-463.
25. Schelbert HR. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography (editorial). J Nucl Med 1993; 33: 1263-1266.
26. Hicks RJ, Herman WH, Kalff V et al. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol 1991; 18: 101-111.
27. Young LH, Seres JA, Lasala JM. Insulin stimulates heart glucose uptake in vivo by increasing the sarcolemma glucose transport vmax. J Am Coll Cardiol 1991; 17: 369A.
28. Schwaiger M, Sun D, England R, Nguyen NTB, Brosius F. Glucose transporter characterization in canine ischemic myocardium. Eur Heart J 1994; 15: 583.
29. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: Its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
30. Fanelli C, Calderone S, Epifano L et al. Demonstration of a critical role for free fatty acids in mediating counterregula-tory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 1993; 92: 1617-1622.
31. Nuutila P, Knuuti MJ, Raitakari M et al. Effect of antilipol-ysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol 1994; 267: E941-E946.
32. Kubota K, Kubota R, Yamada S, Tada M, Takahashi T, Iwata R. Re-evaluation of myocardial FDG uptake in hyperglycemia. J Nucl Med 1996; 37: 1713-1717.